Business Description
HealthEquity Inc
NAICS : 519190
SIC : 8099
ISIN : US42226A1079
Description
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.54 | |||||
| Debt-to-EBITDA | 3.37 | |||||
| Interest Coverage | 3.29 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.64 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.8 | |||||
| 3-Year EBITDA Growth Rate | 16.8 | |||||
| 3-Year EPS without NRI Growth Rate | 57.7 | |||||
| 3-Year FCF Growth Rate | 26.5 | |||||
| 3-Year Book Growth Rate | 9.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 24.75 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.99 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.72 | |||||
| 9-Day RSI | 62.74 | |||||
| 14-Day RSI | 66.44 | |||||
| 6-1 Month Momentum % | 13.38 | |||||
| 12-1 Month Momentum % | 34.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | |||||
| Quick Ratio | 4.1 | |||||
| Cash Ratio | 2.7 | |||||
| Days Sales Outstanding | 33.76 | |||||
| Days Payable | 12.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.7 | |||||
| Shareholder Yield % | -0.39 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.06 | |||||
| Operating Margin % | 16.3 | |||||
| Net Margin % | 9.61 | |||||
| FCF Margin % | -17.99 | |||||
| ROE % | 5.17 | |||||
| ROA % | 3.28 | |||||
| ROIC % | 5.11 | |||||
| ROC (Joel Greenblatt) % | 169.69 | |||||
| ROCE % | 5.95 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 84.62 | |||||
| Forward PE Ratio | 29.2 | |||||
| PE Ratio without NRI | 41.6 | |||||
| Shiller PE Ratio | 206.93 | |||||
| Price-to-Owner-Earnings | 252.59 | |||||
| PEG Ratio | 3.62 | |||||
| PS Ratio | 8.13 | |||||
| PB Ratio | 4.11 | |||||
| Price-to-Operating-Cash-Flow | 29.05 | |||||
| EV-to-EBIT | 52.4 | |||||
| EV-to-Forward-EBIT | 37.21 | |||||
| EV-to-EBITDA | 28.25 | |||||
| EV-to-Revenue | 8.82 | |||||
| EV-to-Forward-Revenue | 7.36 | |||||
| EV-to-FCF | -48.98 | |||||
| Price-to-Projected-FCF | 4.35 | |||||
| Price-to-Median-PS-Value | 0.71 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.05 | |||||
| Earnings Yield (Greenblatt) % | 1.91 | |||||
| FCF Yield % | -2.23 | |||||
| Forward Rate of Return (Yacktman) % | 13.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HealthEquity Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,021.455 | ||
| EPS (TTM) (€) | 1.113 | ||
| Beta | -0.6 | ||
| Volatility % | 27.94 | ||
| 14-Day RSI | 66.44 | ||
| 14-Day ATR (€) | 1.541803 | ||
| 20-Day SMA (€) | 93.15 | ||
| 12-1 Month Momentum % | 34.17 | ||
| 52-Week Range (€) | 57 - 99.5 | ||
| Shares Outstanding (Mil) | 87.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HealthEquity Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HealthEquity Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
HealthEquity Inc Frequently Asked Questions
What is HealthEquity Inc(STU:2HE)'s stock price today?
The current price of STU:2HE is €96.50. The 52 week high of STU:2HE is €99.50 and 52 week low is €57.00.
When is next earnings date of HealthEquity Inc(STU:2HE)?
The next earnings date of HealthEquity Inc(STU:2HE) is 2024-12-09.
Does HealthEquity Inc(STU:2HE) pay dividends? If so, how much?
HealthEquity Inc(STU:2HE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers